Mesenchymal stromal cells secretory pattern contributes to oncoinflammatory bone marrow microenvironment in polycythemia vera. [PDF]
Cominal JG +9 more
europepmc +1 more source
Emerging Significance and Implications of a Durable Complete Molecular Remission in the Treatment of Polycythemia Vera. [PDF]
Duan M +7 more
europepmc +1 more source
Painful diabetic neuropathy complicated with secondary erythromelalgia in polycythemia vera: A case report. [PDF]
Zhang H, Qin Z, Feng X.
europepmc +1 more source
Symptoms, Concomitant Conditions And Cardiac Risk In European Hydroxyurea Treated Polycythemia Vera Patients [PDF]
Anne Graham +3 more
openalex +1 more source
Long-term safety and effectiveness of ruxolitinib in Japanese patients with polycythemia vera: a post-marketing study. [PDF]
Hayashi T, Hongo W, Lu W.
europepmc +1 more source
Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications. [PDF]
Krecak I +11 more
europepmc +1 more source
Efficacy and safety of ropeginterferon alfa-2b in the treatment of polycythemia vera: a systematic review with single arm meta-analysis. [PDF]
Nada EA +10 more
europepmc +1 more source
Expression of Jak2V617F causes a polycythemia vera–like disease with associated myelofibrosis in a murine bone marrow transplant model [PDF]
Gerlinde Wernig +5 more
openalex +1 more source
Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice
Carla Casu +10 more
openalex +1 more source

